4301 - 4325 of 7916 Results
Title
Year
-
OPENTitle: Dietary antioxidants associated with slower progression of parkinsonian signs in older adultsJournal Name: Nutritional NeurosciencePublisher: Informa UK LimitedVol: 25Issue #: 3Start Page: 550End Page: 557Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/1028415x.2020.1769411Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680274Citation Count: 22
-
RESTRICTEDTitle: Pareidolias and cognition in isolated REM sleep behavior disorderJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 76End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.017Citation Count: 9
-
OPENTitle: Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 2Start Page: 320End Page: 331Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25788Best OA location URL: https://doi.org/10.1002/ana.25788Citation Count: 84
-
RESTRICTEDTitle: Sex‐specific association of urate and levodopa‐induced dyskinesia in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 10Start Page: 1948End Page: 1956Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.14337Citation Count: 5
-
RESTRICTEDTitle: LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’sJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00443Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00443/pdfCitation Count: 50
-
OPENTitle: Why People With Parkinson's Disease Experience Near‐Drowning—and How to Prevent ItJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 5Start Page: 573End Page: 574Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12989Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12989Citation Count: 9
-
OPENTitle: A Method of Assessment of Human Natural Killer Cell Phenotype and Function in Whole BloodJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3389/fimmu.2020.00963Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2020.00963/pdfCitation Count: 1
-
RESTRICTEDTitle: Guilt-by-Association – Functional Insights Gained From Studying the LRRK2 InteractomeJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00485Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00485/pdfCitation Count: 10
- Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT2020OPENTitle: Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECTJournal Name: EJNMMI PhysicsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40658-020-00304-zBest OA location URL: https://ejnmmiphys.springeropen.com/track/pdf/10.1186/s40658-020-00304-zCitation Count: 11
-
RESTRICTEDTitle: Transgenic Overexpression of GPNMB Protects Against MPTP-Induced NeurodegenerationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 57Issue #: 7Start Page: 2920End Page: 2933Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-020-01921-6Citation Count: 24
- When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis2020RESTRICTEDTitle: When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysisJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-09892-3Citation Count: 16
- Dopamine is associated with prioritization of reward-associated memories in Parkinson’s disease2020OPENTitle: Dopamine is associated with prioritization of reward-associated memories in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 8Start Page: 2519End Page: 2531Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa182Best OA location URL: https://academic.oup.com/brain/article-pdf/143/8/2519/33773917/awaa182.pdfCitation Count: 15
- Effects of Moderate Static Magnetic Field on Neural Systems Is a Non-invasive Mechanical Stimulation of the Brain Possible Theoretically?2020OPENTitle: Effects of Moderate Static Magnetic Field on Neural Systems Is a Non-invasive Mechanical Stimulation of the Brain Possible Theoretically?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00419Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00419/pdfCitation Count: 19
-
OPENTitle: Mitochondrial tRNA methylation in Alzheimer’s disease and progressive supranuclear palsyJournal Name: BMC Medical GenomicsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12920-020-0727-9Best OA location URL: https://bmcmedgenomics.biomedcentral.com/track/pdf/10.1186/s12920-020-0727-9Citation Count: 13
- Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s Disease2020OPENTitle: Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1087End Page: 1098Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202078Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/221564/221564.pdfCitation Count: 67
-
RESTRICTEDTitle: Senescence as an Amyloid Cascade: The Amyloid Senescence HypothesisJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2020.00129Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2020.00129/pdfCitation Count: 34
- Absence of Sac2/INPP5F enhances the phenotype of a Parkinson’s disease mutation of synaptojanin 12020OPENTitle: Absence of Sac2/INPP5F enhances the phenotype of a Parkinson’s disease mutation of synaptojanin 1Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 22Start Page: 12428End Page: 12434Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2004335117Best OA location URL: https://www.pnas.org/content/pnas/117/22/12428.full.pdfCitation Count: 38
- Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease2020OPENTitle: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 1Start Page: 35End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671949Citation Count: 4
- Inconsistent Movement Disorders Society–Unified Parkinson's Disease Rating Scale Part III Ratings in the Parkinson's Progression Marker Initiative2020OPENTitle: Inconsistent Movement Disorders Society–Unified Parkinson's Disease Rating Scale Part III Ratings in the Parkinson's Progression Marker InitiativeJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1488End Page: 1489Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28108Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022849Citation Count: 10
- Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain2020OPENTitle: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 6Start Page: 696End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-020-0635-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269838Citation Count: 118
-
OPENTitle: Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohortJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01777-2Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-020-01777-2Citation Count: 14
-
OPENTitle: Managing Device‐Aided Treatments in Parkinson's Disease in Times of COVID‐19Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 737End Page: 738Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12985Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12985Citation Count: 2
- Beta Agonists and Progression of Parkinson's Disease in Older Adults: A Retrospective Cohort Study2020RESTRICTEDTitle: Beta Agonists and Progression of Parkinson's Disease in Older Adults: A Retrospective Cohort StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1275End Page: 1277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28085Citation Count: 2
-
OPENTitle: Genetic characterization of Parkinson's disease patients in Ecuador and ColombiaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236935Citation Count: 7
- Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates2020OPENTitle: Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primatesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aaz9165Best OA location URL: https://advances.sciencemag.org/content/advances/6/20/eaaz9165.full.pdfCitation Count: 43